Gestational Diabetes Mellitus in Early Pregnancy: Evidence for Poor Pregnancy Outcomes Despite Treatment
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Recent guidelines recommend testing at <24 weeks of gestation for maternal dysglycemia in “high-risk” women. Evidence to support the early identification and treatment of gestational diabetes mellitus (GDM) is, however, limited. We examined the prevalence, clinical characteristics, and pregnancy outcomes of high-risk women with GDM diagnosed at <24 weeks of gestation (early GDM) and those with pre-existing diabetes compared with GDM diagnosed at ≥24 weeks of gestation, in a large treated multiethnic cohort. RESEARCH DESIGN AND METHODS: Outcomes from 4,873 women attending a university hospital antenatal diabetes clinic between 1991 and 2011 were examined. All were treated to standardized glycemic targets. Women were stratified as pre-existing diabetes (n = 65) or GDM diagnosed at <12 weeks of gestation (n = 68), at 12–23 weeks of gestation (n = 1,247), or at ≥24 weeks of gestation (n = 3,493). RESULTS: Hypertensive disorders in pregnancy including pre-eclampsia, preterm delivery, cesarean section, and neonatal jaundice (all P < 0.001) were more prevalent in women with pre-existing diabetes and early GDM. Macrosomia (21.8% vs. 20.3%, P = 0.8), large for gestational age (39.6% vs. 32.8%, P = 0.4), and neonatal intensive care admission (38.5% vs. 39.7%, P = 0.9) in women in whom GDM was diagnosed at <12 weeks of gestation were comparable to rates seen in women with pre-existing diabetes. CONCLUSIONS: Despite early testing and current best practice treatment, early GDM in high-risk women remains associated with poorer pregnancy outcomes. Outcomes for those in whom GDM was diagnosed at <12 weeks of gestation approximated those seen in pre-existing diabetes. These findings indicate the need for further studies to establish the efficacy of alternative management approaches to improve outcomes in these high-risk pregnancies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, outcomes for women with GDM diagnosed before 12 weeks of gestation are similar to those in women with preexisting diabetes (281).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [281]
In the citing paper
“There is evidence that women diagnosed with GDM early in pregnancy are more likely to have adverse outcomes.”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [281]
Citations
Cites
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122 · cited 1×
“The seminal Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study (1) unequivocally demonstrated a continuouspositive relationshipbetweenmaternal blood glucose levels (BGLs) and several adverse maternal and neonatal outcomes, while intervention studies (7,8) have shown that treatment of GDM after 24 weeks of gestat…”
BackgroundMetzger, B. E., Gabbe, S. G., Persson, B., Lowe, L. P., Dyer, A. R., Oats, J. J. N., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc10-0719 · Cited by 1,888
Maternal Obesity and Risk of Gestational Diabetes Mellitus
Chu, S. Y., Callaghan, W. M., Kim, S. Y., Schmid, C. H., Lau, J., England, L. J., & Dietz, P. M. (2007) · Diabetes Care · doi:10.2337/dc06-2559a · Cited by 1,114
The Hyperglycemia and Adverse Pregnancy Outcome Study
Catalano, P. M., McIntyre, H. D., Cruickshank, J. K., McCance, D. R., Dyer, A. R., Metzger, B. E., Lowe, L. P., Trimble, E. R., Coustan, D. R., Hadden, D. R., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1790 · Cited by 954
(2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.10.012 · Cited by 914
Torloni, M. R., Betrán, A. P., Horta, B. L., Nakamura, M. U., Atallah, A. N., Moron, A. F., & Valente, O. (2009) · Obesity Reviews · doi:10.1111/j.1467-789x.2008.00541.x · Cited by 739
Macintosh, M. C. M., Fleming, K. M., Bailey, J. A., Doyle, P., Modder, J., Acolet, D., Golightly, S., & Miller, A. (2006) · BMJ · doi:10.1136/bmj.38856.692986.ae · Cited by 673
Research works printed but not linked: 1
- Barker, 1994, Mothers, Babies and Diseases in Later Life
Cited by
Items 201–265 of 265
Bernasko, J. (2024) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2024.2373393 · Cited by 3
“…third trimester GDM screening strategy or criteria—if their early pregnancy glycemic exposure is similar, because fasting glycemia in the first [23] and third [15] trimesters correlates with GRAPO, and GRAPO rates in GDM diagnosed early in pregnancy approximate those of preexisting diabetes [24].”
Madugalle, M. E. M. Y. D. B., Rathnayake, C., Rajayohan, T., Kotigala, D. S., & Ruwanpathirana, S. A. (2024) · Open Journal of Obstetrics and Gynecology · doi:10.4236/ojog.2024.1412156 · Cited by 1
Verbessern nationale Leitlinien das Outcome im klinischen Alltag?
Sontag, I., & Adamek, H. E. (2025) · Info Diabetologie · doi:10.1007/s15034-025-5077-4 · Cited by 1
“Die Evidenz für präzisere Empfehlungen nimmt zu, und es häufen sich Hinweise, dass insbesondere der frühe GDM Komplikationen für Mutter und Kind nach sich ziehen kann [13, 14].”
Aktuell geltende Leitlinie Gestationsdiabetes
Schäfer-Graf, U. M. (2019) · Der Diabetologe · doi:10.1007/s11428-019-00553-2 · Cited by 1
Wilkinson, S. A., Palmer, M., Smith, S., Porteous, H., & McCray, S. J. (2021) · International Journal of Evidence-Based Healthcare · doi:10.1097/xeb.0000000000000295 · Cited by 2
Glyburide vs Insulin for Gestational Diabetes
Peng, S., Li, C., & Sun, X. (2018) · JAMA · doi:10.1001/jama.2018.10086 · Cited by 2
Markers of glycation and neonatal hypoglycaemia in gestational diabetes mellitus
Foussard, N., Baillet‐Blanco, L., Poupon, P., Monlun, M., Mohammedi, K., Cougnard‐Grégoire, A., Delcourt, C., Helmer, C., & Rigalleau, V. (2019) · Diabetic Medicine · doi:10.1111/dme.14167 · Cited by 1
Masalin, S. (2021) · Helda - University of Helsinki Institutional Repository · Cited by 4
Xi, G., Ying, Q., Wang, X., Luo, F., Lu, C., Yang, Y. S., & Wang, J. (2020) · doi:10.21203/rs.2.23966/v3 · Cited by 1
Nachum, Z., & Yefet, E. (2017) · Diabetes Care · doi:10.2337/dci17-0016
“(4) found an increased risk for insulin treatment in GDMbefore 24weeks, but oral treatment was not studied.”
BackgroundEarly Weight Gain in Pregnancy and Infant Birth Weight
Rigalleau, V., Cambos, S., & Blanco, L. (2018) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2018.0413
Diabetes Gestacional Precoz: ¿Es útil la glucemia en ayunas?
Megía, A. (2019) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2018.12.001 · Cited by 1
Early gestational diabetes: Is fasting glucose useful?
Megía, A. (2019) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2018.12.002
Webb, H. M. (2020) · Physician Assistant Clinics · doi:10.1016/j.cpha.2019.11.008
DİYABETİK SIÇANLARIN YAVRULARINDA AKCİĞER GELİŞİMİNİN TARAMALI ELEKTRON MİKROSKOBUNDA İNCELENMESİ
Balcıoğlu, E., & Özdamar, S. (2020) · Sağlık Bilimleri Dergisi · doi:10.34108/eujhs.474983
“premature doğum, makrozomi ve ölü doğum gibi birçok olumsuz maternal ve neonatal sonuçlarla ilişkilidir (9).”
Monlun, M., Foussard, N., Blanco, L., Mohammedi, K., & Rigalleau, V. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa397
Monlun, M., Foussard, N., Blanco, L., Mohammedi, K., & Rigalleau, V. (2020) · Journal of Women s Health · doi:10.1089/jwh.2020.8616
Association between gestational diabetes mellitus and allergic diseases in childrenPreprint
Li, Z., Yu, M., Pin, W., Qian, H., Fan, Y., Li, X., Xu, Q., Wang, X., Wang, X., & Lu, C. (2020) · doi:10.22541/au.159969635.51164815
Pregnancy Outcomes Associated with Introduction of Early Diabetes Screening Guidelines
Weiss, R. E., Badreldin, N., Drexler, K. A., Niznik, C. M., & Yee, L. M. (2020) · American Journal of Perinatology · doi:10.1055/s-0040-1721712 · Cited by 1
Xi, G., Ying, Q., Wang, X., Luo, F., Lu, C., Yang, Y. S., & Wang, J. (2020) · doi:10.21203/rs.2.23966/v1
Borissovа, A.-M., Trifonova, B., Dakovska, L. N., Michaylova, E., & Vukov, M. (2021) · International Journal of Diabetes and Endocrinology · doi:10.11648/j.ijde.20210602.13
“GDM increases the risk of adverse pregnancy outcomes, such as pre-eclampsia, more frequent maternal cesarean section, neonatal hypoglycemia, large fetus, birth trauma for the fetus [10].”
BackgroundGuo, Z., Shan, Y., Xiu, C., Yang, Y., Zheng, S., & Peng, M. (2020) · doi:10.21203/rs.3.rs-32012/v1
“A large multiethnic cohort study conducted by Sweeting et al[17] showed that incidence of macrosomia, large for gestational age and neonatal intensive care admission in women in whom GDM was diagnosed at < 12 weeks of gestation was high and even comparable to women with pre-existing diabetes.”
ResultRuiz, D., Santibáñez, M., Alio-Lavín, B., Alvarez, I. M., Berja, A., Montalbán, C., & Vázquez, L. A. (2021) · Research Square · doi:10.21203/rs.3.rs-588198/v1
Gestationsdiabetes und polyzystisches Ovarialsyndrom
Kollmann, M. (2021) · Journal für Klinische Endokrinologie und Stoffwechsel · doi:10.1007/s41969-021-00143-y
To study effects of early screening for gestational diabetes mellitus on maternal and fetal outcome
Bajaj, S., & Madnani, D. N. (2021) · International Journal of Clinical Obstetrics and Gynaecology · doi:10.33545/gynae.2021.v5.i4c.983
Paganoti, C. D. F. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2020.tde-05032021-140813
Managing Gestational Diabetes During and After Pregnancy
Egan, A. M., & Dunne, F. (2021) · Wiley eBooks · doi:10.1002/9781119603207.ch6 · Cited by 1
Unintended and unwanted pregnancy in St. Lucia.
Denton, A., Chase, W. M., & Scott, K. (1994) · PubMed
Risk factors for newly diagnosed hyperglycemia in pregnancy
Plekhanovа, M. A., Фархадовна, Б. Ф., Petrukhin, V. A., & Ovchinnikova, V. V. (2022) · Russian Bulletin of Obstetrician-Gynecologist · doi:10.17116/rosakush20222201174 · Cited by 1
Xi, G., Ying, Q., Wang, X., Luo, F., Lu, C., Yang, Y. S., & Wang, J. (2020) · doi:10.21203/rs.2.23966/v2
Shinde, A. K. (2021) · Interventions in Gynaecology and Women’s Healthcare · doi:10.32474/igwhc.2021.04.000189
Diabète gestationnel précoce et risque obstétrical
(2016) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(16)30219-2
Gestational Diabetes and its Therapeutic Nutritional Care
Maqsood, M., Ain, H. B. U., Naqoosh, A., Naqoosh, R., Tufail, T., Amjad, A., Imran, M., Imran, S., & Saleem, A. (2022) · Pakistan BioMedical Journal · doi:10.54393/pbmj.v5i5.445
Kuyoro, O., McLaren, R. A., Narayanamoorthy, S., Weedon, J., & MINKOFF, H. L. (2022) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2022.2089553
Tanpong, S., & Boriboonhirunsarn, D. (2022) · Research Square · doi:10.21203/rs.3.rs-1915590/v1
Munir, S. I., Khalil, N., Khokhar, S. J., & Sayyed, B. (2022) · Pak-Euro Journal of Medical and Life Sciences · doi:10.31580/pjmls.v5i1.2452 · Cited by 1
“Swaroop et al. in India (13) and Sweeting et al. (18) in Australia reported similar distribution of primiparas (34.0”
BackgroundInfluentialDiabetesscreening in der Schwangerschaft
Schäfer-Graf, U. M. (2023) · Die Gynäkologie · doi:10.1007/s00129-022-05041-1
“AuchwenndieBlutzuckerwerte noch unterhalb der Diabeteskriterien liegen, haben Schwangerschaften mit einer Hyperglykämie vor 24 SSW – unterhalb eines manifesten Diabetes – vergleichbare hoheRisikenwie Frauenmit präkonzeptionell bekanntem Diabetes (u. a. perinatale Mortalität, neonatale Hypoglykämien, Insulintherapie; […”
Association between Anthropometry and Gestational Diabetes Mellitus
Bodhinarayana, T. N., & Karunarathne, M. (2023) · Open Journal of Obstetrics and Gynecology · doi:10.4236/ojog.2023.133050
The Importance of Early Diagnosis for Gestational Diabetes Mellitus
Lee, M. J. (2023) · Journal of Korean Diabetes · doi:10.4093/jkd.2023.24.2.55 · Cited by 1
Goyal, A., Gupta, Y., & Tandon, N. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-7959-7.00067-1
Impact of youth onset type 2 diabetes during pregnancy on microvascular and cardiac outcomes
Tryggestad, J. B., Drews, K. L., Mele, L., Arslanian, S. A., Chernausek, S. D., Escaname, E. N., Geffner, M. E., ISGANAITIS, E. M., Sprague, J., & Kelsey, M. M. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110876
Khan, Z. A., Khail, S. K., Ahmad, P., Munir, S., & Usman, M. (2024) · Journal of Shifa Tameer-e-Millat University · doi:10.32593/jstmu/vol7.iss1.319
Salomé, N., Gichuhi, J. W., & Mokomba, A. (2021) · Journal of Obstetrics and Gynaecology of Eastern and Central Africa · doi:10.59692/jogeca.v33i4.461 · Cited by 1
Solaja, O. A., Babs-Fashola, O. F., Ajakaye, I. O., Bayode, F. J., Emelifonwu, U. G., Okon, A. E., Ajibade, A. B., & Adeleye, A. M. (2025) · International Journal of Gynaecology and Obstetrics Sciences · doi:10.33545/26649004.2025.v7.i1b.42
Screening auf Gestationsdiabetes: Ab welchem Grenzwert drohen Komplikationen?
Sontag, I., & Adamek, H. E. (2025) · Info Diabetologie · doi:10.1007/s15034-025-5138-8
Balabanova, K. S., Krasnopolskaya, K. V., Petrukhin, V. A., Burumkulova, F. F., Kovalenko, T. S., Garina, A. O., & Shmakov, R. G. (2025) · Russian Bulletin of Obstetrician-Gynecologist · doi:10.17116/rosakush20252506137
Janssen, S. M. W., Bouzembrak, Y., Cuypers, M., Tekinerdogan, B., & Leusink, G. (2026) · Frontiers in Endocrinology · doi:10.2196/preprints.89370
Kakuto, Y., Ohara, M., Koide, K., Osamura, A., Matsuura, R., Yamagishi, S., & Sekizawa, A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14248796
“Furthermore, traditional risk factors, such as maternal age, pre-pregnancy body mass index (BMI), and excessive gestational weight gain, have been considered insufficient to fully predict which patients will experience perinatal complications [11–13].”
田野翔, Kotani, T., Ushida, T., Yoshihara, M., Imai, K., Nakamura, N., Iitani, Y., Moriyama, Y., Emoto, R., Kato, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26596007
田野翔, Kotani, T., Ushida, T., Yoshihara, M., Imai, K., Nakamura, N., Iitani, Y., Moriyama, Y., Emoto, R., Kato, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26596013
Deng, Y., Jin, H., Ning, J., Cui, D., Zhang, M., & Yang, H. (2024) · Figshare · doi:10.6084/m9.figshare.26612891
Jokelainen, M., Kautiainen, H., Nenonen, A., Stach‐Lempinen, B., & Klemetti, M. M. (2024) · Figshare · doi:10.6084/m9.figshare.25303048
田野翔, Kotani, T., Ushida, T., Yoshihara, M., Imai, K., Nakamura, N., Iitani, Y., Moriyama, Y., Emoto, R., Kato, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26596010
Deng, Y., Jin, H., Ning, J., Cui, D., Zhang, M., & Yang, H. (2024) · Figshare · doi:10.6084/m9.figshare.26612900
Deng, Y., Jin, H., Ning, J., Cui, D., Zhang, M., & Yang, H. (2024) · Figshare · doi:10.6084/m9.figshare.26612897
Deng, Y., Jin, H., Ning, J., Cui, D., Zhang, M., & Yang, H. (2024) · Figshare · doi:10.6084/m9.figshare.26612894
Alkahtani, K., Mahjoub, M. M., Takroni, Z. M., Ibrahim, K., Zeyad, L. A., Tayb, M. S., Alteibawi, M. A., Almuzayen, H., Sahl, Y. M., Rabeh, H. M. A., et al. (2026) · Cureus · doi:10.7759/cureus.102898
“…by milder hyperglycemia (e.g., FPG 5.1-6.9 mmol/L), representing a distinct high-risk phenotype often characterized by more severe insulin resistance and β -cell dysfunction than standard GDM [7,9], reflecting undiagnosed pre-pregnancy dysglycemia rather than accelerated gestational pathology.”
InfluentialAgarwal, P., Thakur, N., & Agrawal, S. (2026) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20260562
Liu, Q., Sun, M., & Xu, Z. (2026) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-026-01673-4
Wood, A. J., O’Hara, C., Joyce-Tubb, A., Webster, V., Wicks, M., Dokkum, P. V., Maple-Brown, L. J., & Hare, M. J. L. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-110242
“Research examining potential barriers and strategies on how best to support T2D care for Aboriginal mothers and families in the remote NT could be instrumental in improving pregnancy outcomes for current and future generations.”
Taşdemir, D., & Haksever, M. (2026) · Anatolian Current Medical Journal · doi:10.38053/acmj.1909404
Jaggi, S., Chawla, R., Ss, G., Jaggi, C., Chawla, Y., & Chawla, S. (2026) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-026-01701-3
Aksoy, R. T., & Tonyalı, N. V. (2026) · Kırıkkale Üniversitesi Tıp Fakültesi Dergisi · doi:10.24938/kutfd.1926420
Lopez, F. N. L., Villar‐Taibo, R., Díaz‐López, E. J., Cantón-Blanco, A., Rodríguez-Carnero, G., Andújar-Plata, P., Díaz-Trastoy, O., Fernández-Argüeso, M., Gómez-Vázquez, E., & Olmos, M. Á. M. (2026) · Endocrines · doi:10.3390/endocrines7030047
“Furthermore, early diagnosis of GDM has been associated with an increased risk of long-term maternal metabolic complications, such as postpartum glucose intolerance or subsequent development of type 2 diabetes [14].”
Bilyalova, G., Baibusunova, A., Boshanova, A., Akylzhanova, Z., (Idrisov), A. I., Turgumbayeva, A., Biktashev, D., Baubekova, A., Kulbayeva, S., Azanbayeva, D., et al. (2026) · Biomedicines · doi:10.3390/biomedicines14102340
“%) that did not differ significantly from those of 65 women with pre-existing diabetes; with fewer than 70 women per group, this indicates an absence of demonstrated difference rather than equivalence [12].”
Metadata
- Authors
- Sweeting, A. N., Ross, G. P., Hyett, J., Molyneaux, L., Constantino, M., Harding, A. J., & Wong, J.
- Affiliations
- The University of Sydney (AU)
- Royal Prince Alfred Hospital (AU)
- Corresponding author
- Sweeting, Arianne N.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2015-12-05
- Volume
- 39
- Issue
- 1
- Pages
- 75-81
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2209588964
- Semantic Scholar
- c01f8c75daf8185a9473a20188d2f730be4af574
- Cited by
- 263
- References
- 36
- Citations by year
- 2026: 12 · 2025: 24 · 2024: 32 · 2023: 30 · 2022: 33 · 2021: 30 · 2020: 40 · 2019: 22 · 2018: 21 · 2017: 10 · 2016: 8
- FWCI
- 14.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- gestational diabetes mellitus, early pregnancy diagnosis, pregestational diabetes, high-risk pregnancy, glycemic control, hypertensive disorders of pregnancy, preeclampsia, preterm birth, cesarean section, neonatal jaundice, macrosomia, large for gestational age, neonatal intensive care admission, pregnancy outcomes
- MeSH terms
- Adult, Birth Weight, Blood Glucose, Cesarean Section, Female, Fetal Macrosomia, Humans, Infant, Newborn, Jaundice, Neonatal, Pre-Eclampsia, Pregnancy, Pregnancy Complications, Pregnancy Outcome, Cohort Studies, Diabetes, Gestational, Premature Birth
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.